You are now leaving Lundbeck South Africa

You are now leaving



Terms of Use

Our Full Terms of Use

Terms of Use for

Lundbeck ensures that reasonable care is being taken to ensure that the website content is accurate and up-to-date, but all information is provided ‘as is’ and Lundbeck makes no warranties or representations of any kind as to accuracy, sequence, timeliness or completeness of the website content and may at any time at its sole discretion change or replace the information on the website and discontinue distributing the site without prior notice.

Terms and Conditions

By using the website, you agree to be bound by the Website Terms and Conditions

The website is owned and provided by:
H. Lundbeck A/S, 
Ottiliavej 9, 
2500 Valby, 

and any of its affiliates (“Lundbeck”, “we”, “us” or “our”)

Company registration number: 56 75 99 13
Telephone number: + 45 3630 1311

More from Lundbeck

Investor Relations 

Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP Investor Relations. + 45 3083 2426 

About Us 

A global pharmaceutical company specialized in brain diseases.


For general press enquiries, please call + 45 3643 4000